PROCHÁZKOVÁ, Dagmar, Jiří JARKOVSKÝ, Petra KONEČNÁ, Hana BENAKOVÁ and Hana VINOHRADSKÁ. Does long-term treatment for hyperphenylalaninemia and phenylketonuria create a risk of vitamin B12 nutritional deficiency? In Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Lyon, France, JIMD, 2015, 38, Supl. 1, s.87. 2015. ISSN 0141-8955.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Does long-term treatment for hyperphenylalaninemia and phenylketonuria create a risk of vitamin B12 nutritional deficiency?
Authors PROCHÁZKOVÁ, Dagmar, Jiří JARKOVSKÝ, Petra KONEČNÁ, Hana BENAKOVÁ and Hana VINOHRADSKÁ.
Edition Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Lyon, France, JIMD, 2015, 38, Supl. 1, s.87, 2015.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30209 Paediatrics
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.541
Organization unit Faculty of Medicine
ISSN 0141-8955
Keywords (in Czech) vitamin B12 holotranskobalamin PKU HPA
Keywords in English vitamin B12 holotranscobalamin PKU HPA
Changed by Changed by: doc. MUDr. Dagmar Procházková, Ph.D., učo 45686. Changed: 28/8/2015 09:49.
Abstract
The present study suggests that adult PKU and HPA patients were at risk of developing vitamin B12 deficiency. The best marker for the monitoring is holotranscobalamin in serum.
Abstract (in Czech)
Dospělí dlouhodobě léčení pacienti s PKU a HPA jsou v riziku nutričního deficitu vitaminu B12. K monitorování je nejvhodnější holotranskobalamin v krvi.
PrintDisplayed: 29/9/2024 09:54